首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >DEVELOPMENT AND VALIDATION OF AN HPLC-MS/MS METHOD FOR SIMULTANEOUS DETERMINATION OF IVERMECTIN, FEBANTEL, PRAZIQUANTEL, PYRANTEL PAMOATE AND RELATED COMPOUNDS IN FIXED DOSE COMBINATION FOR VETERINARY USE
【24h】

DEVELOPMENT AND VALIDATION OF AN HPLC-MS/MS METHOD FOR SIMULTANEOUS DETERMINATION OF IVERMECTIN, FEBANTEL, PRAZIQUANTEL, PYRANTEL PAMOATE AND RELATED COMPOUNDS IN FIXED DOSE COMBINATION FOR VETERINARY USE

机译:HPLC-MS / MS法同时测定固定剂量组合中兽用伊维菌素,Febantel,吡喹酮,吡喃酰胺及相关化合物的建立和验证

获取原文
           

摘要

High performance liquid chromatography with tandem mass spectrometry (HPLC-MS/MS) method for simultaneous quantification of ivermectin, febantel, praziquantel and pyrantel pamoate in addition to the qualitative determination of febantel-related compound C and praziquantel-related compounds A, B and C in tablets was developed and validated. Chromatographic separations were achieved using isocratic elutio n (200 μL/min) on a C8 column (50 x 2.1 mm i.d) coupled with a C8 (10 x 2.1 mm i.d) guard column maintained at 20 .C. The mobile phase consisted in water/acetonitrile (15:85 v/v) containing 0.1% formic acid and 3 mmol/L ammonium formate. The injection volume used was 20 μL. The validation parameters indicated that the method has high sensitivity and selectivit y with excellent linearity (r .0.99). The observed range of recovery was 93.26% to 101.36% with a RSD of <5% for intraday and interday precision. Sample analyses demonstrated a lack of standardization in the amounts of these drugs, which may contribute to their toxicity or a reduction in efficacy, depending of the sample used. The proposed HPLC-MS/MS method is presented as an alternative option for the quality control of pharmaceutical preparations containing these drugs
机译:高效液相色谱-串联质谱法(HPLC-MS / MS)用于同时定量伊维菌素,非班特尔,吡喹酮和吡ant酸酯的定量,此外还定性测定了非班特尔相关化合物C和吡喹酮相关化合物A,B和C在平板电脑上的开发和验证。使用等度洗脱液(200μL/ min)在C8色谱柱(50 x 2.1 mm i.d)和保持在20°C的C8(10 x 2.1 mm i.d)保护柱上进行色谱分离。流动相为水/乙腈(15:85 v / v),其中含有0.1%的甲酸和3 mmol / L的甲酸铵。使用的进样量为20μL。验证参数表明,该方法灵敏度高,选择性好,线性好(r .0.99)。日间和日间精度的观察到的恢复范围为93.26%至101.36%,相对标准偏差<5%。样品分析表明这些药物的数量缺乏标准化,这可能会导致其毒性或功效降低,具体取决于所使用的样品。提出的HPLC-MS / MS方法是包含这些药物的药物制剂质量控制的替代选择

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号